The efficacy and safety of induction chemoradiotherapy (ICRT) followed by surgery in stage III NSCLC patients (pts) with T3/4-adjacent organ invasion involved(AOI): A single-center retrospective observational study.

M. Nemoto (Kamogawa, Japan), M. Misawa (Kamogawa, Japan), H. Nomori (Kamogawa, Japan), A. Tateishi (Kamogawa, Japan), R. Tsuzuki (Kamogawa, Japan), A. Otsuki (Kamogawa, Japan), K. Nakashima (Kamogawa, Japan), Y. Oyama (Kamogawa, Japan), H. Sugimura (Kamogawa, Japan), K. Shoji (Kamogawa, Japan), M. Aoshima (Kamogawa, Japan)

Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2223
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Nemoto (Kamogawa, Japan), M. Misawa (Kamogawa, Japan), H. Nomori (Kamogawa, Japan), A. Tateishi (Kamogawa, Japan), R. Tsuzuki (Kamogawa, Japan), A. Otsuki (Kamogawa, Japan), K. Nakashima (Kamogawa, Japan), Y. Oyama (Kamogawa, Japan), H. Sugimura (Kamogawa, Japan), K. Shoji (Kamogawa, Japan), M. Aoshima (Kamogawa, Japan). The efficacy and safety of induction chemoradiotherapy (ICRT) followed by surgery in stage III NSCLC patients (pts) with T3/4-adjacent organ invasion involved(AOI): A single-center retrospective observational study.. 2223

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: